British American Tobacco (BATS) Receives a Buy from Kepler Capital
In a report released on February 12, Emanuele Sartori from Kepler Capital maintained a Buy rating on British American Tobacco, with a price target of p4,900.00.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, Sartori is a 2-star analyst with an average return of 2.7% and a 66.67% success rate.
In addition to Kepler Capital , British American Tobacco also received a Buy from Jefferies’s Andrei Andon Ionita in a report issued on February 12. However, on the same day, RBC Capital maintained a Sell rating on British American Tobacco (LSE: BATS).
Based on British American Tobacco’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p12.07 billion and a net profit of p4.49 billion. In comparison, last year the company earned a revenue of p12.34 billion and had a net profit of p4.49 billion
Based on the recent corporate insider activity of 97 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BATS in relation to earlier this year.
Read More on GB:BATS:
Disclaimer & DisclosureReport an Issue
- BAT files 2025 annual reports and flags rising illicit trade risk
- British American Tobacco Cancels New Tranche of Buyback Shares
- British American Tobacco: Justified Valuation Discount Amid Muted Growth and Earnings Risk Driving Sell Rating
- British American Tobacco: Earnings Beat, Cost Savings and Valuation Discount Reinforce Buy Rating
- BAT Extends Share Buyback With New Santander Mandate to Cancel Shares
